Vaxart Inc. Stock
Vaxart Inc. Stock
A very strong showing by Vaxart Inc. today, with an increase of €0.020 (4.650%) compared to yesterday's price.
The community is currently still undecided about Vaxart Inc. with 2 Buy predictions and 0 Sell predictions.
For the coming years our community has positive and negative things to say abot the Vaxart Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Vaxart Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vaxart Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vaxart Inc. | 4.650% | 0.000% | -8.163% | -32.836% | 60.714% | -46.619% | -91.667% |
| Larimar Therapeutics Inc. | -2.400% | -6.154% | -21.290% | -19.205% | -26.506% | -57.565% | -82.695% |
| Celldex Therapeutics | -3.030% | 0.524% | -15.044% | -10.280% | -12.727% | -50.566% | -17.241% |
| Achieve Life Sciences Inc. | -2.340% | -1.660% | -22.969% | 18.303% | -3.919% | -26.091% | -67.973% |
Comments
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AVIR provided by MarketBeat
News
The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway)
Penny stocks attract speculative investors looking for high-risk/high-reward opportunities. That means looking for companies with disruptive technologies, that are part of an emerging trend, or
